Dummer R, Long GV, Robert C, Tawbi HA, et al. Randomized Phase III Trial Evaluating Spartalizumab Plus Dabrafenib and Trametinib for BRAF V600-Mutant Unresectable or Metastatic Melanoma. J Clin Oncol 2022 Jan 14:JCO2101601. doi: 10.1200/JCO.21.01601.
PMID: 35030011